Skip to navigation Skip to content

Clinical Trial: Effect of the Ataxia Crutch on walking in MS

Share

Details
Type of MS: PPMS|PRMS|RRMS|SPMS
Treatment mode of action: To improve walking
Number of Subjects: 14
Medication: Ataxia Crutch
Location: Connecticut|Massachusetts|New Hampshire|Rhode Island|Vermont
Institutions: Massachusetts College of Pharmacy and Health Sciences
Address:10 Lincoln Square, WORCESTER, MA Contact Information
Erin Faraclas, PT, DPT, PhD
413.896.5686
erin.faraclas@mcphs.edu

Funding:

faculty grant from Massachusetts College of Pharmacy and Health Sciences

Description

I am recruiting adults with Multiple Sclerosis who currently walk using an assistive device (cane, walker, crutches, and trekking poles) to participate in a study. The goal of the study is to learn whether the Ataxia Balance Crutch is an effective device for people with MS.  

Participating involves two research visits to MCPHS University. You will be asked to complete surveys. You will also be asked to walk over special surfaces with your current assistive device and the Ataxia Balance Crutch.  You will be asked to use the Ataxia Balance Crutch for 2 weeks between visits. Each research visit will last between 90 minutes and two hours.

Inclusion Criteria:  Adults with Multiple Sclerosis who use an assistive device (cane, walker, crutches, and trekking pole) for walking.  You must be able to walk 500 feet, be able to come to Worcester on two different occasions, be at least 18 years or older, and understand directions in English or Portuguese.  

Exclusion Criteria: If you have previously used the Ataxia Balance Crutch or if you use a wheelchair for most of your walking or mobility needs, you do not qualify to participate in this research.
 

Share


© 2024 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.